YOLFTbeta
Merck KGaA

Merck KGaA

MRK · XETRA · Healthcare / Drug Manufacturers - Specialty & Generic

143.25EUR+1.35 (+0.95%)

Price History

Full chart

Market Stats

Previous Close141.9
Open142.95
Day Range142.1 – 143.7
52-Week Range98.72 – 148.8
Volume251.45K
Market Cap59.15B
P/E (TTM)24.96
Forward P/E14.84
EPS5.45
Dividend Yield1.61%
Beta0.79
50-Day Avg137.77
200-Day Avg127.54

About

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a sub

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEODr. Kai Beckmann
  • Employees62.14K
  • HeadquartersFrankfurter Strasse 250, Darmstadt, Germany, 64293, Germany
  • Websitehttps://www.merckgroup.com

Leadership

  • Dr. Kai BeckmannCEO & Chair of Management Board · b. 1965
  • Ms. Helene von RoederCFO & Member of Executive Board · b. 1970
  • Mr. Danny Pinhas Bar-Zohar M.D.Member of the Executive Board & CEO of Healthcare · b. 1970
  • Mr. Jean Charles WirthMember of the Executive Board & CEO Life Science · b. 1973
  • Ms. Khadija Ben HammadaMember of the Executive Board & Chief People Officer · b. 1980
  • Mr. Benjamin HeinMember of Management Board & CEO of Electronics Business Sector
  • Florian SchraederHead of Investor Relations
  • Mr. Axel LoberHead of Global Communications
  • Mr. Frank GotthardtHead of Corporate & Government Relations - Europe
  • Mr. Marc HornHead of Life Science Controlling · b. 1975

Financials

Income Statement

Line item2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue7.40B7.20B5.34B5.77B4.46B7.06B7.56B7.75B9.29B10.28B11.17B11.10B11.36B12.84B15.02B14.52B14.84B16.15B17.53B19.69B22.23B20.99B21.16B21.10B
Cost of Revenue3.79B3.57B2.32B2.37B1.58B2.34B2.48B2.65B3.20B3.79B4.03B3.81B4.36B4.92B6.34B6.11B6.43B7.00B7.55B8.09B9.39B9.32B9.21B9.21B
Gross Profit3.60B3.63B3.02B3.40B2.88B4.72B5.08B5.10B6.09B6.49B7.14B7.29B7.00B7.92B8.69B8.40B8.41B9.15B9.98B11.60B12.84B11.67B11.95B11.89B
Operating Income494.80M579.30M515.60M742.10M696.40M1.43B1.11B890.00M1.25B1.16B1.82B2.09B1.83B2.11B2.37B2.01B1.75B2.00B3.15B4.28B5.00B4.04B4.37B4.07B
EBITDA920.00M1.01B1.34B1.00B962.70M2.35B1.96B1.78B2.27B2.41B3.14B3.33B3.09B3.50B4.17B3.77B3.50B3.90B4.91B5.88B6.28B5.52B5.55B5.45B
Net Income215.20M217.70M658.60M658.90M983.10M29.20M367.10M366.30M632.10M606.51M566.70M1.20B1.16B1.11B1.63B2.60B1.13B1.32B1.99B3.06B3.33B2.82B2.78B2.61B
R&D608.20M604.60M599.00M713.00M615.40M1.03B1.23B1.34B1.40B1.51B1.51B1.50B1.70B1.71B1.97B2.11B2.20B2.26B2.29B2.40B2.45B2.44B2.27B2.38B
Interest Expense147.70M115.40M43.50M33.60M50.60M321.90M84.90M88.70M208.90M227.20M221.90M176.60M159.80M291.60M277.00M282.00M254.00M476.00M387.00M244.00M194.00M255.00M211.00M262.00M

Balance Sheet

Line item2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.51B6.98B5.72B7.28B8.10B14.92B15.64B16.71B22.39B22.12B21.64B20.82B26.01B38.01B38.25B35.62B36.89B43.81B41.80B45.36B48.53B48.49B51.57B52.10B
Total Liabilities5.46B4.62B2.83B3.95B4.30B6.23B6.02B7.20B12.02B11.63B11.23B9.75B14.21B25.15B24.20B21.55B19.66B25.90B24.78B23.95B22.52B21.74B21.58B23.44B
Total Equity2.01B2.33B2.85B3.28B3.75B8.63B9.51B9.46B10.33B10.45B10.36B11.02B11.74B12.79B13.99B14.00B17.20B17.86B16.95B21.34B25.93B26.68B29.91B28.59B
Cash339.40M297.80M369.70M1.32B460.10M426.60M692.70M541.40M943.70M937.80M729.70M980.80M2.88B832.20M939.00M589.00M2.17B541.00M1.11B1.51B1.40B1.98B2.15B2.74B
Total Debt----------4.29B3.70B5.64B13.53B28.04B24.12B22.00B27.27B27.65B33.19B10.40B9.94B10.27B11.97B
Net Debt-339.40M-297.80M-369.70M-1.32B-460.10M-426.60M-692.70M-541.40M-943.70M-937.80M3.56B2.72B2.76B12.70B11.53B10.12B6.63B12.58B10.93B9.26B9.00B7.96B8.12B9.23B

Cash Flow

Line item2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow421.70M752.40M570.90M732.50M811.70M1.22B1.02B1.37B1.78B1.27B2.47B2.23B2.71B2.20B2.52B2.70B2.22B2.86B3.48B4.62B4.26B3.78B4.59B3.93B
Investing Cash Flow19.80M-310.40M1.31B-195.20M-1.46B-2.73B-81.70M-2.16B-3.88B-896.00M-1.16B-874.50M-1.64B-11.94B-503.00M-1.15B2.19B-6.15B-1.34B-1.58B-2.74B-1.89B-3.05B-4.26B
Financing Cash Flow517.10M-460.60M-1.72B440.40M-195.50M1.49B-666.70M637.20M2.54B-384.10M-1.52B-1.07B760.50M7.16B-1.91B-1.87B-2.83B1.90B-1.52B-2.50B-1.55B-1.73B-985.00M628.00M
Capital Expenditure411.80M306.40M255.10M299.50M309.80M403.90M535.60M563.90M500.40M446.00M473.30M516.60M624.20M693.00M848.00M1.31B1.02B1.02B1.56B1.42B1.81B2.02B2.18B1.58B
Free Cash Flow9.90M446.00M315.80M433.00M501.90M814.40M488.40M807.40M1.28B825.20M2.00B1.71B2.08B1.50B1.67B1.39B1.20B1.83B1.91B3.19B2.45B1.76B2.40B2.35B
Dividends Paid49.50M53.90M44.20M57.80M49.70M77.00M212.50M104.80M86.10M86.80M102.60M414.40M505.50M564.20M597.00M621.00M755.00M677.00M680.00M748.00M955.00M1.15B284.00M1.04B

Earnings

Report DateFeb 16, 2004Apr 22, 2004Apr 23, 2008Jul 23, 2008Oct 27, 2008Feb 18, 2009Apr 27, 2009Jul 24, 2009Oct 26, 2009Feb 23, 2010Apr 29, 2010Jul 29, 2010Oct 27, 2010Feb 21, 2011Apr 28, 2011Jul 27, 2011Oct 26, 2011Mar 6, 2012May 15, 2012Aug 14, 2012Nov 15, 2012Mar 6, 2013May 14, 2013Aug 9, 2013Nov 14, 2013Mar 6, 2014May 15, 2014Aug 13, 2014Nov 13, 2014Mar 3, 2015May 19, 2015Aug 6, 2015Nov 12, 2015Mar 8, 2016May 19, 2016Aug 4, 2016Nov 15, 2016Mar 9, 2017May 18, 2017Aug 3, 2017Nov 9, 2017Mar 8, 2018May 15, 2018Aug 9, 2018Nov 13, 2018Mar 7, 2019May 14, 2019Aug 8, 2019Nov 14, 2019Mar 4, 2020May 12, 2020Aug 6, 2020Nov 12, 2020Mar 3, 2021May 12, 2021Aug 4, 2021Nov 10, 2021Mar 2, 2022May 12, 2022Aug 4, 2022Nov 10, 2022Mar 2, 2023May 11, 2023Aug 3, 2023Nov 9, 2023Mar 6, 2024May 15, 2024Jul 31, 2024Nov 13, 2024Mar 6, 2025May 15, 2025Aug 7, 2025Nov 13, 2025Mar 5, 2026May 13, 2026Aug 6, 2026Nov 12, 2026
EPS Estimate----------0.540.650.72-0.890.960.87-0.870.910.951.01-1.111.091.092.231.171.171.141.141.201.211.171.421.531.561.531.721.551.481.351.381.301.261.331.241.491.401.541.501.332.221.582.182.072.202.062.412.522.642.452.282.181.931.851.871.912.272.192.162.142.201.941.922.052.06
EPS Actual-0.110.260.550.480.46-0.640.130.250.330.130.440.430.490.110.940.560.960.310.840.960.991.020.611.131.151.061.161.161.151.141.121.301.321.131.541.551.701.431.801.541.511.311.411.231.321.221.131.541.351.541.501.302.341.572.182.242.242.062.412.642.682.322.362.202.071.862.062.202.302.072.122.022.321.881.522.16-
Surprise-----------18.52%-33.85%-31.94%-5.62%-41.67%10.34%--3.45%5.49%4.21%0.99%-1.80%5.50%-2.75%-47.98%-0.85%-1.71%0.00%-1.75%8.33%9.09%-3.42%8.45%1.31%8.97%-6.54%4.65%-0.65%2.03%-2.96%2.17%-5.38%4.76%-8.27%-8.87%3.36%-3.57%0.00%0.00%-2.26%5.41%-0.63%0.00%8.21%1.82%0.00%0.00%4.76%1.52%-5.31%3.51%0.92%7.25%0.54%10.16%15.18%1.32%-5.42%-1.85%-5.61%5.45%-3.09%-21.20%5.37%-
Timing----------After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursAfter-hours-After-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap59.15B
Enterprise Value66.15B
Trailing P/E24.96
Forward P/E14.84
PEG Ratio2.15
Price / Sales2.80
Price / Book1.95
EPS5.45
Book Value69.58
Revenue (TTM)21.13B
Gross Profit (TTM)12.49B
EBITDA5.59B
Profit Margin11.21%
Operating Margin13.86%
Return on Equity8.13%
Return on Assets4.65%
Shares Outstanding129.24M
Shares Float128.87M
Beta0.79
Dividend Yield1.61%
Dividend Rate2.2
Payout Ratio27.93%

Dividends

20261×
2.20Apr 27, 2026
20251×
2.20Apr 28, 2025
20241×
2.20Apr 29, 2024
20231×
2.20May 2, 2023
20221×
1.85Apr 25, 2022
20211×
1.40Apr 26, 2021
20202×
1.30May 29, 20201.30Apr 27, 2020
20191×
1.25Apr 29, 2019
20181×
1.25Apr 30, 2018
20171×
1.20May 2, 2017
20161×
1.05May 2, 2016
20151×
1.00Apr 20, 2015
20141×
0.95May 12, 2014
20131×
0.85Apr 29, 2013
20121×
0.75Apr 23, 2012
20111×
0.63Apr 11, 2011
20101×
0.50Apr 12, 2010
20091×
0.75Apr 4, 2009
20081×
1.00Mar 31, 2008
20071×
0.45Apr 30, 2007
20061×
0.42Jul 3, 2006
20051×
0.10Apr 1, 2005
20041×
0.39Mar 29, 2004

Stock Splits

  • Jun 30, 20142:1
  • Jan 24, 20071367:1346